Literature DB >> 17211574

Glomerular mesangial fibrillary deposits in a patient with diabetes mellitus.

Ipek Isik Gonul1, James Gough, Kim Jim, Hallgrimur Benediktsson.   

Abstract

Various systemic or primary glomerular diseases can result in deposition of fibrillary material in the glomerular tuft and may cause an important diagnostic challenge for the pathologists. Biopsy findings of a patient with type 2 diabetes is presented here in which striking fibrillary structures were identified in the mesangium by ultrastructural examination. The distinction between diabetic fibrillosis and fibrillary glomerulonephritis accompanying diabetic nephropathy is discussed in the setting of a literature review.

Entities:  

Mesh:

Year:  2007        PMID: 17211574     DOI: 10.1007/s11255-006-9034-4

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

1.  Fibrillary glomerulonephritis: a report of 2 cases with extensive glomerular and tubular deposits.

Authors:  O A Adeyi; S Sethi; H G Rennke
Journal:  Hum Pathol       Date:  2001-06       Impact factor: 3.466

2.  Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease.

Authors:  M B Stokes; S Holler; Y Cui; K L Hudkins; F Eitner; A Fogo; C E Alpers
Journal:  Kidney Int       Date:  2000-02       Impact factor: 10.612

3.  Microfibrils are a major component of the mesangial matrix in the glomerulus of the rat kidney.

Authors:  P Mundel; M Elger; T Sakai; W Kriz
Journal:  Cell Tissue Res       Date:  1988-10       Impact factor: 5.249

4.  Nephrotic syndrome associated with amyloid-like glomerular deposits.

Authors:  E Rosenmann; M Eliakim
Journal:  Nephron       Date:  1977       Impact factor: 2.847

5.  Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia.

Authors:  N A Wahab; K Harper; R M Mason
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

6.  Glomerulopathies with fibrillary deposits.

Authors:  J A King; R M Culpepper; G R Corey; J A Tucker; G Lajoie; D N Howell
Journal:  Ultrastruct Pathol       Date:  2000 Jan-Feb       Impact factor: 1.094

7.  When noncongophilic glomerular fibrils do not represent fibrillary glomerulonephritis: nonspecific mesangial fibrils in sclerosing glomeruli.

Authors:  J D Kronz; A M Neu; T Nadasdy
Journal:  Clin Nephrol       Date:  1998-10       Impact factor: 0.975

8.  Clinical and pathologic features of fibrillary glomerulonephritis.

Authors:  S S Iskandar; R J Falk; J C Jennette
Journal:  Kidney Int       Date:  1992-12       Impact factor: 10.612

9.  Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy.

Authors:  A Fogo; N Qureshi; R G Horn
Journal:  Am J Kidney Dis       Date:  1993-09       Impact factor: 8.860

10.  Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.

Authors:  Jordan L Rosenstock; Glen S Markowitz; Anthony M Valeri; Giuseppe Sacchi; Gerald B Appel; Vivette D D'Agati
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.